Literature DB >> 7568174

A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin 6, transforming growth factor beta 1, or platelet-derived growth factor B gene.

M Yoshida1, J Sakuma, S Hayashi, K Abe, I Saito, S Harada, M Sakatani, S Yamamoto, N Matsumoto, Y Kaneda.   

Abstract

Interstitial pneumonia is characterized by alveolitis with resulting fibrosis of the interstitium. To determine the relevance of humoral factors in the pathogenesis of interstitial pneumonia, we introduced expression vectors into Wistar rats via the trachea to locally overexpress humoral factors in the lungs. Human interleukin (IL) 6 and IL-6 receptor genes induced lymphocytic alveolitis without marked fibroblast proliferation. In contrast, overexpression of human transforming growth factor beta 1 or human platelet-derived growth factor B gene induced only mild or apparent cellular infiltration in the alveoli, respectively. However, both factors induced significant proliferation of fibroblasts and deposition of collagen fibrils. These histopathologic changes induced by the transforming growth factor beta 1 and platelet-derived growth factor B gene are partly akin to those changes seen in lung tissues from patients with pulmonary fibrosis and markedly contrast with the changes induced by overexpression of the IL-6 and IL-6 receptor genes that mimics lymphocytic interstitial pneumonia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7568174      PMCID: PMC40843          DOI: 10.1073/pnas.92.21.9570

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop.

Authors:  E J Battegay; E W Raines; R A Seifert; D F Bowen-Pope; R Ross
Journal:  Cell       Date:  1990-11-02       Impact factor: 41.582

Review 2.  Cytokines of the lung.

Authors:  J Kelley
Journal:  Am Rev Respir Dis       Date:  1990-03

3.  Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo.

Authors:  M Saito; K Yoshida; M Hibi; T Taga; T Kishimoto
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

4.  Inhibition of skin development by overexpression of transforming growth factor beta 1 in the epidermis of transgenic mice.

Authors:  K Sellheyer; J R Bickenbach; J A Rothnagel; D Bundman; M A Longley; T Krieg; N S Roche; A B Roberts; D R Roop
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

5.  Direct injection of hepatitis B virus DNA into liver induced hepatitis in adult rats.

Authors:  K Kato; Y Kaneda; M Sakurai; M Nakanishi; Y Okada
Journal:  J Biol Chem       Date:  1991-11-25       Impact factor: 5.157

6.  Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. A potential mechanism for the recruitment and activation of neutrophils in lung fibrosis.

Authors:  P C Carré; R L Mortenson; T E King; P W Noble; C L Sable; D W Riches
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

7.  Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure.

Authors:  Y Zhang; T C Lee; B Guillemin; M C Yu; W N Rom
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

8.  Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney.

Authors:  Y Isaka; Y Fujiwara; N Ueda; Y Kaneda; T Kamada; E Imai
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

9.  Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis.

Authors:  T J Broekelmann; A H Limper; T V Colby; J A McDonald
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

10.  Human alveolar macrophage cytokine release in response to in vitro and in vivo asbestos exposure.

Authors:  R C Perkins; R K Scheule; R Hamilton; G Gomes; G Freidman; A Holian
Journal:  Exp Lung Res       Date:  1993 Jan-Mar       Impact factor: 2.459

View more
  35 in total

1.  Increased level of soluble E-selectin in the serum from patients with idiopathic pulmonary fibrosis.

Authors:  Seiji Hayashi; Kin'ya Abe; Hiroto Matsuoka; Sho Goya; Hiroshi Morishita; Masahide Mori; Toru Arai; Hiroshi Kida; Kazumi Nishino; Yoshito Takeda; Tadashi Osaki; Isao Tachibana; Kentaro Kimura; Soichiro Yokota; Yoshikazu Inoue; Mitsunori Sakatani
Journal:  Inflammation       Date:  2004-02       Impact factor: 4.092

2.  Changes in pulmonary histology and exfoliated bronchoalveolar cells induced by in vivo introduction of the tumor necrosis factor-alpha gene.

Authors:  J Sakuma-Mochizuki; M Yoshida; K Abe; T Arai; M Mori; Y Kaneda; S Hayashi
Journal:  Inflammation       Date:  2000-02       Impact factor: 4.092

Review 3.  Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets.

Authors:  Justin C Hewlett; Jonathan A Kropski; Timothy S Blackwell
Journal:  Matrix Biol       Date:  2018-04-03       Impact factor: 11.583

4.  Platelet-derived growth factor causes pulmonary cell proliferation and collagen deposition in vivo.

Authors:  E S Yi; H Lee; S Yin; P Piguet; I Sarosi; S Kaufmann; J Tarpley; N S Wang; T R Ulich
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

5.  Identification of Helicobacter pylori VacA in human lung and its effects on lung cells.

Authors:  Shota Nakashima; Tomoyuki Kakugawa; Hirokazu Yura; Masaomi Tomonaga; Tatsuhiko Harada; Atsuko Hara; Shintaro Hara; Masayuki Nakano; Eiki Yamasaki; Noriho Sakamoto; Yuji Ishimatsu; Hajime Isomoto; Bernadette R Gochuico; Anthony F Suffredini; Hiroshi Mukae; Hisao Kurazono; Toshiya Hirayama; Joel Moss; Shigeru Kohno
Journal:  Biochem Biophys Res Commun       Date:  2015-03-25       Impact factor: 3.575

6.  Keratinocyte growth factor decreases pulmonary edema, transforming growth factor-beta and platelet-derived growth factor-BB expression, and alveolar type II cell loss in bleomycin-induced lung injury.

Authors:  E S Yi; M Salgado; S Williams; S J Kim; E Masliah; S Yin; T R Ulich
Journal:  Inflammation       Date:  1998-06       Impact factor: 4.092

7.  Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats.

Authors:  A B Rice; C R Moomaw; D L Morgan; J C Bonner
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

8.  Sex Hormones and Lung Inflammation.

Authors:  Jorge Reyes-García; Luis M Montaño; Abril Carbajal-García; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice.

Authors:  Yuanjue Zhu; Yong Liu; Weixun Zhou; Ruolan Xiang; Lei Jiang; Kewu Huang; Yu Xiao; Zijian Guo; Jinming Gao
Journal:  Respir Res       Date:  2010-03-20

Review 10.  Markers of early disease and prognosis in COPD.

Authors:  Morten Dahl; Børge G Nordestgaard
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.